» Articles » PMID: 29387113

Magnesium Sulfate Protects the Heart Against Carbon Monoxide-induced Cardiotoxicity in Rats

Overview
Journal Res Pharm Sci
Specialty Chemistry
Date 2018 Feb 2
PMID 29387113
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Carbon monoxide (CO), a toxic gas produced via incomplete fossil fuel combustion, has several poisonous effects in the heart including induction of necrosis, apoptosis, and electrocardiogram (ECG) changes. Magnesium sulfate (MS) is a drug with cardioprotective effects especially when used after ischemia/reperfusion. In the current study, we aimed to evaluate MS cardioprotective effects following CO poisoning. Animals were exposed to CO 3000 ppm for 1 h and immediately after the exposure period and on the next 4 days (a total of 5 consecutive doses given on a daily basis), MS (75, 150 and 300 mg/kg) was injected intraperitoneally (i.p.) and ECG was recorded focusing on ST-segment, T-wave, and Q-pathologic wave changes. On day 5, animals were sacrificed and their heart was excised for determination of BAX, BCL2 and Akt expression level using western blot analysis and necrosis investigations. The results showed that MS significantly decreased necrosis and BAX/BCL2 ratio ( < 0.001) while pro-survival protein Akt was significantly increased ( < 0.001). Moreover, CO-induced ST-segment depression, T-wave inversion, and atrioventricular block (AV-block) were decreased following treatment with MS. In conclusion, our results showed that MS could decrease cardiac deleterious effects of CO poisoning including necrosis and apoptosis while increased the expression of Akt, as a cell survival protein.

Citing Articles

Serum glucose/potassium ratio as an indicator of early and delayed outcomes of acute carbon monoxide poisoning.

Elmansy A, Hannora D, Khalifa H Toxicol Res (Camb). 2024; 13(5):tfae168.

PMID: 39381599 PMC: 11457236. DOI: 10.1093/toxres/tfae168.


Hesperidin neuroprotective effects against carbon monoxide-induced toxicity in male rats.

Shahraki J, Tabrizian K, Rezaee R, Tashakori B, Dadrezaei S, Ghorani V Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7673-7681.

PMID: 38700797 DOI: 10.1007/s00210-024-03132-5.


Exogenous carbon monoxide promotes GPX4-dependent ferroptosis through ROS/GSK3β axis in non-small cell lung cancer.

Cao W, Sun M, Yu K, Zhao L, Feng Y, Tan C Cell Death Discov. 2024; 10(1):42.

PMID: 38263152 PMC: 10805785. DOI: 10.1038/s41420-023-01743-0.


Carbon monoxide poisoning.

Kinoshita H, Turkan H, Vucinic S, Naqvi S, Bedair R, Rezaee R Toxicol Rep. 2020; 7:169-173.

PMID: 32015960 PMC: 6992844. DOI: 10.1016/j.toxrep.2020.01.005.


Magnesium sulfate ameliorates carbon monoxide‑induced cerebral injury in male rats.

Bagheri G, Rezaee R, Tsarouhas K, Docea A, Shahraki J, Shahriari M Mol Med Rep. 2018; 19(2):1032-1039.

PMID: 30569139 PMC: 6323247. DOI: 10.3892/mmr.2018.9771.

References
1.
Dastjerdi M, Babazadeh Z, Rabbani M, Gharagozloo M, Esmaeili A, Narimani M . Effects of disulfiram on apoptosis in PANC-1 human pancreatic cancer cell line. Res Pharm Sci. 2015; 9(4):287-94. PMC: 4314877. View

2.
Mohamadpour A, Moallem S, Hashemzaei M, Abnous K, Tabatabaee Yazdi S, Imenshahidi M . Effects of granulocyte colony-stimulating factor on electrocardiogram changes after carbon monoxide poisoning in rats. Drug Chem Toxicol. 2011; 35(4):353-60. DOI: 10.3109/01480545.2011.627863. View

3.
Hanci V, Ayoglu H, Yurtlu S, Yildirim N, Okyay D, Erdogan G . Effects of acute carbon monoxide poisoning on the P-wave and QT interval dispersions. Anadolu Kardiyol Derg. 2011; 11(1):48-52. DOI: 10.5152/akd.2011.009. View

4.
Hashemzaei M, Imen Shahidi M, Moallem S, Abnous K, Ghorbani M, Mohamadpour A . Modulation of JAK2, STAT3 and Akt1 proteins by granulocyte colony stimulating factor following carbon monoxide poisoning in male rat. Drug Chem Toxicol. 2016; 39(4):375-9. DOI: 10.3109/01480545.2015.1123267. View

5.
Woods K, Fletcher S, Roffe C, Haider Y . Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992; 339(8809):1553-8. DOI: 10.1016/0140-6736(92)91828-v. View